Global Drug Screening Market Report 2017-2024 Focuses On Top Companies like Siemens Healthcare GmbH (Germany), Thermo Fisher Scientific, Inc. (U.S.), Hoffmann -La Roche Ltd(Switzerland), BioMerieux SA (France), and Shimadzu Corporation (Japan)

Global Drug Screening Market By Products and Services (Immunoassay Analyzers, Chromatography, Breath Analyzers, Rapid Testing Devices, Assay Kits and Reagents), Sample Type (Urine, Breath, Saliva, Hair, Blood, Skin, Sweat)Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024

The market accounted to USD 5.7 billion in 2016 at a CAGR of 12.50% during the forecast period of 2017 to 2024.

Inquire for Sample@ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-drug-screening-market

The global drug screening market is segmented on the basis of product and services, sample type, and geography.

Based on Products and Services Type:
• Immunoassay Analyzers
• Chromatography
• Breath Analyzers
• Rapid Testing Devices
• Assay Kits
• Reagent
Based on Sample Type:
• Urine,
• Breath
• Saliva
• Hair
• Blood
• Skin
• Sweat

Talk to the Author of the Report: http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-drug-screening-market

Based on geography the market is segmented into 5 geographical regions such as North America, Europe, Asia-Pacific, South America, Middle East and Africa. The geographical regions are further segmented into major countries such as U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.

Some of the major players operating in global drug screening market are Siemens Healthcare GmbH (Germany), Quest Diagnostics Incorporated (U.S.), Alere (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Laboratory Corporation of America Holdings (U.S.), Abbott (U.S.), Hoffmann -La Roche Ltd(Switzerland), BioMerieux SA (France), Express Diagnostics Int’l, Inc. (U.S.), Drägerwerk AG & Co. KGaA (Germany), Bio-Rad Laboratories Inc. (U.S), Biomedical Diagnostics (Belgium), CannAmm (Canada), MPD, Inc. (U.S.), Danaher (U.S.), Synergy Health plc. (U.K),Agilent Technologies (U.S.), and Shimadzu Corporation (Japan) among others.

Browse Full Report @ http://databridgemarketresearch.com/reports/global-drug-screening-market/

Related Report

Global Drug Delivery Devices Market – Trends and Forecast to 2024

Global Drug Delivery Devices Market, By Route of Administration (Oral, Injectable, Topical, Pulmonary, Nasal, Ocular, Implantable, Transmucosal), End-User (Hospitals, Clinics, Home Care Settings), Distribution Channel (Direct Tenders,Hospital Pharmacies), Geography (North America, Europe, Asia-Pacific, South America, Middle East Africa) – Trends and Forecast To 2024

http://databridgemarketresearch.com/reports/global-drug-delivery-devices-market/

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sales@databridgemarketresearch.com
Investor: investors@databridgemarketresearch.com
Visit Blog http://databridgemarketresearch.com/blog/
Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research

This release was published on openPR.